Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Guangxi LiuYao Group Co., Ltd (603368.SS)
CNY15.92
+0.24 (+1.53%)
CN SHH Healthcare Medical - Distribution
Address
No. 68, Guantang Avenue 545001
Liuzhou, CN
Liuzhou, CN
CEO
Chaoyang Zhu
Website
lzyy.cn
IPO
2014-12-04
ISIN CNE100001VR3
Description
Guangxi LiuYao Group Co., Ltd., a company established in 1981 and headquartered in Liuzhou, China, focuses on the wholesale and retail of pharmaceutical goods across the Chinese market. Furthermore, it operates as a subsidiary of Liuzhou Liangmianzhen Co., Ltd.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY15.92
+0.24 (+1.53%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.34
Float Shares
381.48M
Free Float %
96.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.65% | -0.56% | -4.24% | -10.85% | -10.60% | -10.04% | -4.53% | -31.14% | -22.56% | -43.54% | +8.16% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
15.92
DCF (Unlevered)
61.23
+284.6%
DCF (Levered)
154.96
+873.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.21
Grey zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
5 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Distribution: +5.6%-1.2% Q1'26: +1.1% (vs Q1'25)
-
EPS growth Medical - Distribution: +4.9%-19.0% Q1'26: -8.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Distribution: +37.6%+3.0% ★ Q1'26: -10.3% (vs Q1'25)
-
EBIT margin Medical - Distribution: +3.0%+5.2% ★ Q1'26: +5.8% (vs Q1'25)
-
ROIC Medical - Distribution: +5.7%+12.1% ★ Q1'26: +10.2% (vs Q1'25)
-
Share dilution Medical - Distribution: +0.0%+2.5% Q1'26: -11.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Distribution: 0.87×2.43× ★ Q1'26: 3.20× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6.51B
est: 6.41B (+1.5%)
|
7.56B
est: 7.98B (-5.3%)
|
9.45B
est: 9.40B (+0.5%)
|
11.71B
est: 11.80B (-0.7%)
|
14.86B
est: 14.67B (+1.3%)
|
15.67B
est: 15.67B (+0.0%)
|
17.13B
est: 17.30B (-1.0%)
|
19.05B
est: 19.07B (-0.1%)
|
20.81B
est: 20.80B (+0.1%)
|
21.18B
est: 21.31B (-0.6%)
|
20.93B
est: 21.17B (-1.1%)
|
21.98B
21.98B – 21.98B
+3.8% YoY
|
23.15B
23.15B – 23.15B
+5.3% YoY
|
24.28B
24.28B – 24.28B
+4.9% YoY
|
| EBITDA |
307.19M
est: 415.04M (-26.0%)
|
401.22M
est: 516.89M (-22.4%)
|
536.48M
est: 608.38M (-11.8%)
|
739.40M
est: 763.91M (-3.2%)
|
1.07B
est: 949.87M (+12.2%)
|
1.14B
est: 1.01B (+12.3%)
|
1.02B
est: 1.12B (-9.2%)
|
1.20B
est: 1.23B (-3.1%)
|
1.38B
est: 1.35B (+2.2%)
|
1.33B
est: 1.36B (-2.4%)
|
1.29B
est: 1.35B (-4.6%)
|
1.40B
1.40B – 1.40B
+3.8% YoY
|
1.48B
1.48B – 1.48B
+5.3% YoY
|
1.55B
1.55B – 1.55B
+4.9% YoY
|
| EBIT |
297.75M
est: 384.04M (-22.5%)
|
387.88M
est: 478.28M (-18.9%)
|
511.27M
est: 562.93M (-9.2%)
|
701.57M
est: 706.84M (-0.7%)
|
1.01B
est: 878.91M (+15.2%)
|
1.07B
est: 938.64M (+13.7%)
|
932.44M
est: 1.04B (-10.1%)
|
1.10B
est: 1.14B (-3.5%)
|
1.28B
est: 1.25B (+2.5%)
|
1.22B
est: 1.21B (+1.3%)
|
1.09B
est: 1.20B (-9.1%)
|
1.25B
1.25B – 1.25B
+3.8% YoY
|
1.31B
1.31B – 1.31B
+5.3% YoY
|
1.38B
1.38B – 1.38B
+4.9% YoY
|
| Net Income |
208.38M
est: 279.34M (-25.4%)
|
321.01M
est: 329.44M (-2.6%)
|
401.38M
est: 443.07M (-9.4%)
|
528.19M
est: 556.05M (-5.0%)
|
685.43M
est: 762.59M (-10.1%)
|
711.71M
est: 800.72M (-11.1%)
|
563.82M
est: 750.43M (-24.9%)
|
701.52M
est: 729.80M (-3.9%)
|
849.59M
est: 895.49M (-5.1%)
|
854.87M
est: 881.81M (-3.1%)
|
709.46M
est: 768.92M (-7.7%)
|
677.76M
677.76M – 677.76M
-11.9% YoY
|
705.50M
705.50M – 705.50M
+4.1% YoY
|
745.14M
745.14M – 745.14M
+5.6% YoY
|
| SGA |
207.00M
est: 299.02M (-30.8%)
|
230.62M
est: 372.40M (-38.1%)
|
289.57M
est: 438.31M (-33.9%)
|
420.42M
est: 550.36M (-23.6%)
|
588.91M
est: 684.33M (-13.9%)
|
668.11M
est: 730.84M (-8.6%)
|
819.78M
est: 807.16M (+1.6%)
|
903.62M
est: 889.36M (+1.6%)
|
983.61M
est: 970.31M (+1.4%)
|
1.02B
est: 889.19M (+14.5%)
|
377.16M
est: 883.24M (-57.3%)
|
917.20M
917.20M – 917.20M
+3.8% YoY
|
965.73M
965.73M – 965.73M
+5.3% YoY
|
1.01B
1.01B – 1.01B
+4.9% YoY
|
| EPS |
0.73
est: 0.72 (+0.5%)
|
1.19
est: 0.85 (+39.7%)
|
1.11
est: 1.15 (-3.1%)
|
1.46
est: 1.44 (+1.6%)
|
1.89
est: 1.97 (-4.1%)
|
1.96
est: 2.07 (-5.3%)
|
1.56
est: 1.94 (-19.6%)
|
1.94
est: 1.89 (+2.8%)
|
2.35
est: 2.32 (+1.3%)
|
2.21
est: 2.22 (-0.5%)
|
1.79
est: 1.94 (-7.7%)
|
1.71
1.71 – 1.71
-11.9% YoY
|
1.78
1.78 – 1.78
+4.1% YoY
|
1.88
1.88 – 1.88
+5.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-25 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
920.90M
OE per share TTM
2.28
Owner's Yield
16.37%
Maintenance CapEx ratio
18.50%
Maint CapEx / Avg PPE
6.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 19 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 222.6K | 0.39% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 37.0K | 0.46% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 231.7K | 0.06% |
| 4 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 7.5K | 0.44% |
| 5 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 73.2K | 0.29% |
| 6 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 78.0K | 0.28% |
| 7 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 7.8K | 0.48% |
| 8 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 17.7K | 0.26% |
| 9 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 871.6K | 0.06% |
| 10 | Vanguard Total World Stock ETF VT | 0.00% | 287.1K | 0.06% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
195.5K
Shares Outstanding
397.21M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chaoyang Zhu | Chairman & Chief Executive Officer | — | male |
| Chunxue Tang | Vice President & Director | — | female |
| Jun Xiong Xiao | Vice President | — | male |
| Xian Rong Tang | Vice President | — | male |
| Xiangxing Zeng | Vice President, Chief Financial Officer & Accounting Supervisor | — | male |
| Xianhua Zhu | Vice President & Director | — | male |
| Yang Xu | Secretary | — | male |
| Zhen Liang | Vice President | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603368.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
